HER-FLOT: Trastuzumab in combination with FLOT as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Journal of Clinical Oncology

Abbreviated Title: JCO

Publisher: American Society of Clinical Oncology (ASCO)

ISSN (Print): 0732-183X

ISSN (Electronic): 1527-7755

Publication date Created: May 20 2014

Publication date (Print): May 20 2014

Volume: 32

Issue: 15_suppl

Page: 4073

Affiliations

[1 ]University Hospital Mannheim, Mannheim, Germany

[2 ]Study GBR Hamburg, Hamburg, Germany

[3 ]Charité Campus Virchow Klinik, Berlin, Berlin, Germany

[4 ]Medizinische Klinik und Poliklinik II, University of Wuerzburg, Würzburg, Germany

[5 ]Krankenhaus Bogenhausen, München, Germany

[6 ]Kliniken Maria Hilf, Mönchengladbach, Germany

[7 ]Department of Internal Medicine II, Academic Teaching Hospital Wolfsburg, Wolfsburg, Germany

[8 ]Department of Medical Oncology, Klinikum Grosshadern, University of Munich, Munich, Germany

[9 ]Ruhr-Universität Bochum, Bochum, Germany

[10 ]Institute for Pathology, Ruhr-University, Bochum, Germany

[11 ]Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt am Main, Germany

Article

DOI: 10.1200/jco.2014.32.15_suppl.4073

SO-VID: 6f065df3-b6e9-46dd-a918-ee2fe8a4abdd

History

Data availability:

Comments

Comment on this article

scite_

Cited by 9

See all cited by